Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding
NCT00874653 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 78
Last updated 2014-06-23
Summary
The purposes of this study are:
* To evaluate patient satisfaction for efficacy and tolerability of heavy menstrual bleeding treatment by Mirena.
* To collect italian data for Mirena in clinical routine.
Conditions
- Menorrhagia
Interventions
- DRUG
-
Levonorgestrel (Mirena, BAY86-5028)
Women using Mirena for intrauterine treatment of menorrhagia
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bayer Study Director · Bayer
Eligibility
- Min Age
- 30 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-04-30
- Completion
- 2008-12-31
Countries
- Italy
More Related Trials
-
Non-interventional Study of Long-term Intrauterine Contraceptives Acceptability and User Satisfaction
NCT01590537 ·Status: COMPLETED
-
Study in Women With Idiopathic Menorrhagia to Determine the Reduction in Menstrual Blood Loss (MBL) After Treatment With the Levonorgestrel-releasing Intrauterine System (IUS)
NCT00360490 ·Status: COMPLETED ·Phase: PHASE3
-
Mirena Extension Trial
NCT02985541 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
NCT01074892 ·Status: COMPLETED ·Phase: PHASE4
-
MIRENA for Contraception In InDian Subjects User continuAtion and Satisfaction Study: MIDAS Study
NCT01961375 ·Status: COMPLETED
-
Mirena Post-marketing Surveillance in Japan
NCT01414140 ·Status: COMPLETED
-
Mirena Observational Program
NCT00883662 ·Status: COMPLETED
-
Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)
NCT01295294 ·Status: COMPLETED ·Phase: PHASE4
-
Acceptability of Long-term Progestin-only Contraception in Europe
NCT00931827 ·Status: COMPLETED
-
Therapeutic Equivalence Trial of Two Hormonal-IUDs in Patients With Heavy Menstrual Bleeding
NCT01695902 ·Status: COMPLETED ·Phase: PHASE3
-
HR-QoL and Sexuality in Mirena Inserted Contraception Users
NCT00498784 ·Status: COMPLETED ·Phase: PHASE4
-
Descriptive, Prospective, Non-interventional Study (NIS) to Describe Mirena and Amenorrhea Related Acceptability in Contraception Indication in Medical Practice
NCT01833793 ·Status: COMPLETED
-
Dose-finding Study for the Ultralow-dose Levonorgestrel Intrauterine Contraceptive System (LCS)
NCT00185380 ·Status: COMPLETED ·Phase: PHASE2
-
Mirena Efficiency and Tolerability During the First Year of Use
NCT00696202 ·Status: COMPLETED ·Phase: PHASE4
-
Case-Control-Study on the Breast Cancer Risk of Mirena® Compared With Copper IUDs
NCT00461253 ·Status: COMPLETED
-
Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women
NCT01499602 ·Status: COMPLETED ·Phase: NA
-
Scandinavian Mirena Insertion Nulliparous Trial.
NCT00798980 ·Status: COMPLETED
-
Pretreatment With Mifepristone Prior to Mirena Insertion
NCT01931657 ·Status: COMPLETED ·Phase: PHASE2
-
Mirena and Estrogen for Control of Perimenopause Symptoms and Ovulation Suppression
NCT01613131 ·Status: COMPLETED ·Phase: NA
-
Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer
NCT00788671 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding
NCT03642210 ·Status: COMPLETED ·Phase: PHASE3
-
Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study
NCT01309919 ·Status: COMPLETED ·Phase: NA
-
Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
NCT05316493 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development
NCT02490774 ·Status: TERMINATED ·Phase: PHASE2
-
LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia
NCT04385667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3